Join us on Thursday, September 26, from 12 to 1 p.m. for an overview of the risk assessment process and updates on new program developments. Risk assessments are a powerful tool that organizations can utilize to examine the safety environment of an institution or service line. Understanding structure, culture and leadership components elucidate strengths and opportunities for improvement that are actionable. Guest speaker Sarah Kadish, Vice President of Quality and Patient Safety at Dana-Farber Cancer Institute (DFCI), will share DFCI’s journey with you and describe how their team used risk assessment findings to expand their safety culture. Register now: https://hubs.li/Q02MzDgG0
CRICO’s Post
More Relevant Posts
-
CNSA is pleased to offer the following sponsored lectures at the 50th Annual Meeting: 🧠Early High Efficacy Treatment in MS by Stephen Yeung, DO, sponsored by Novartis 🧠Problem-Based Learning: 68-Year-Old Man With Progressive Weakness by Salman Bhai, MD, and Gil Wolfe, MD, sponsored by Grifols 🧠It's Not You, It's Me. Communication Misalignment and Strategies to Close the Migraine Treatment Gap by Hope O'Brien, MD, MBA sponsored by Eli Lilly and Company 🧠Diagnosing and Treating Hyperkinetic Movement Disorders: Tardive Dyskinesia and Huntington's Disease Chorea by Jaime Hatcher-Martin, MD, PhD, FAAN and Stuart Isaacson, MD sponsored by Neurocrine Biosciences
-
-
In this on-demand webinar, Dr. Sarosh Rana, MD, MPH discusses the scientific evidence and clinical impact of implementing the angiogenic biomarkers into the management of preeclampsia with severe features. #thermofisheremp
-
Dive deep into AdAlta featuring Andrew Musgrave and Tim Oldham, CEO & Managing Director AdAlta. Tim discusses AdAlta's revolutionizing treatments with our unique i-body platform. Our lead product, AD-214, is showing promise in treating fibrotic diseases. Here's what you'll learn: · AdAlta's mission and focus areas · The groundbreaking i-body technology and its advantages · Exciting updates on the Phase I clinical trials and partnering for AD-214 · Strategic partnerships boosting R&D efforts · The establishment of cellular immunotherapy initiative AdCella and its impact · AdAlta's vision for the future Tune in here: https://lnkd.in/gDabUQVa
-
-
Teaching Research Methodology & Biostatistics to Healthcare Professionals | Helping doctors grow their practice and personal brand through personalized social media strategies.
Understanding the difference between 𝐜𝐨𝐫𝐫𝐞𝐥𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐜𝐚𝐮𝐬𝐚𝐭𝐢𝐨𝐧 is crucial in research, yet many get it wrong! 🔗𝐂𝐨𝐫𝐫𝐞𝐥𝐚𝐭𝐢𝐨𝐧: When two variables move together, but one doesn’t necessarily cause the other. For example, ice cream sales and sunburn cases increase at the same time, but ice cream doesn’t cause sunburn! 🌞🍦 💥 𝐂𝐚𝐮𝐬𝐚𝐭𝐢𝐨𝐧: This is when one variable directly causes a change in another. In healthcare, identifying causality is crucial for treatments. For example, smoking causes lung cancer, a proven causal relationship backed by research. ✅ What you should know: Just because two things are linked (correlated) doesn’t mean one is the reason for the other. To prove causation, you need rigorous study designs like randomized controlled trials. 🚀 If you're struggling with research terminology like this, our 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐌𝐞𝐭𝐡𝐨𝐝𝐨𝐥𝐨𝐠𝐲 & 𝐁𝐢𝐨𝐬𝐭𝐚𝐭𝐢𝐬𝐭𝐢𝐜𝐬 𝟏𝟎𝟏 group coaching program will make these concepts crystal clear! DM me or WhatsApp 𝟖𝟑𝟏𝟖𝟔𝟕𝟗𝟕𝟐𝟓 to join our next cohort starting on Nov 4th. Limited seats available—don’t miss out on mastering the essentials! 🎓📊 #CorrelationVsCausation #ResearchTerminology #HealthcareResearch #MedicalResearch101 #Biostatistics101 #ResearchMethodology #ResearchMastery #MedicalEducation #DataAnalysis #SPSS
-
-
The diagnosis and treatment of sepsis have always been a challenge for the physician, especially in critical care settings. Among the biomarkers of sepsis, Presepsin appears to be the most promising biomarker due to its multiple clinical and diagnostic advantages. #TosohIndia #KnowledgeInnovationSupport #sepsis #stopsepsis #savelives #sepsisawareness #presepsin
-
-
Proud to share my graduation project presentation! Titled "Overcoming the Dilemma Behind Fibromyalgia By Exploring Possible Biomarkers," our presentation dives into the complexities of diagnosing this condition and the potential role of new biomarkers in improving the lives of patients. 🧬#fibromyalgia #biomarkers #diagnosis #graduationproject
-
Navigating a difficult discussion about cancer in the workplace can be challenging, but it's a chance to make sure your employees are well-supported. Is your management team ready? Get our complimentary guide to assist them in supporting employees facing cancer: https://bit.ly/3Srczpi. #SupportThroughCancer #EmployeeWellness.
Are your line managers prepared? | Free guide to help them support employees through cancer
reframe.co.uk
-
A study presented at ECTRIMS2024 has identified key biomarkers that can accurately predict disability progression in multiple sclerosis (MS). These findings have the potential to significantly impact MS treatment approaches, enabling the development of more personalized and effective therapeutic strategies tailored to individual patient profiles. 🔗Follow along as we cover the 2024 ECTRIMS Congress: https://lnkd.in/dasAixGB #ECTRIMS24 #MS
ECTRIMS 2024: New Data Has the Potential to Paving the Way for More Personalised and Effective Treatment Plans
https://bpno.se
-
A study presented at ECTRIMS2024 has identified key biomarkers that can accurately predict disability progression in multiple sclerosis (MS). These findings have the potential to significantly impact MS treatment approaches, enabling the development of more personalized and effective therapeutic strategies tailored to individual patient profiles. 🔗Follow along as we cover the 2024 ECTRIMS Congress: https://lnkd.in/dUhdWu6v #ECTRIMS24 #MS
ECTRIMS 2024: New Data Has the Potential to Paving the Way for More Personalised and Effective Treatment Plans
https://bpno.no
